MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.thromres.2025.109412

Медицинская библиотека · Thrombosis research · 2025

Characterization of a novel factor X variant, p.F139L, associated with bleedings in heterozygous and compound heterozygous form.

Hellum Marit, Sletten Marit, Le Marie S, Stavseth Vidar, Glosli Heidi, Backe Paul Hoff, Iversen Nina, Henriksson Carola E

СтатьяКлинический случайПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

INTRODUCTION

Congenital factor X (FX) deficiency is a rare bleeding disorder. Heterozygous patients may experience bleedings like epistaxis or bleeding complications after dental extraction and surgery, whereas homozygous individuals often experience more severe bleedings.

AIM: To characterize a new FX variant found in two unrelated probands with mild to moderate bleeding tendencies.

METHODS

Prothrombin time (PT) Quick, APTT, FX activity, FX antigen, thrombin generation and DNA sequencing were performed for probands and their families. F10 variants were explored in programs for in silico predictions and structural analyses, and in vitro expression was used for further characterization.

RESULTS

A novel missense variant (c.415T>C, p.F139L) was found in heterozygous form in proband 1 and in compound heterozygous form in proband 2, in combination with a previously known missense variant (c.424G>A, p.E142K). All individuals carrying the p.F139L variant had borderline/prolonged PT Quick (11.9-15.9 s) and APTT (36-43 s) and reduced thrombin generation. Both FX antigen (30-51 %) and activity (37-63 IU/dL) were reduced, indicating a type I deficiency. Structural analysis indicated that interactions between the EGF-2 and the protease domain of FX could be disrupted in the p.F139L variant, causing destabilization of the protein. The p.E142K variant was predicted to have less impact on FX structure. In vitro expression results further supported plasma findings.

CONCLUSION

We report a new FX variant, p.F139L, causing a type I FX deficiency associated with mild to moderate bleedings in heterozygous and compound heterozygous form. The variant causes structural changes which likely affect intracellular processing of FX.

Для цитирования: Hellum Marit, Sletten Marit, Le Marie S, Stavseth Vidar, Glosli Heidi, Backe Paul Hoff, Iversen Nina, Henriksson Carola E. Characterization of a novel factor X variant, p.F139L, associated with bleedings in heterozygous and compound heterozygous form.. Thrombosis research. 2025. DOI: 10.1016/j.thromres.2025.109412.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.